The 2nd International standard for Interleukin-2 (IL-2) Report of a collaborative study (original) (raw)
Distinct Clinical and Laboratory Activity of Two Recombinant Interleukin-2 Preparations
Jacquelyn Hank
Clinical Cancer Research, 1999
View PDFchevron_right
Purification and characterization of a high-molecular-weight form of recombinant human Interleukin2
Doreen Ciolek
Journal of Protein Chemistry, 1994
View PDFchevron_right
Pharmacokinetics of recombinant interleukin 2 in humans
Roland Mertelsmann
Cancer research, 1990
View PDFchevron_right
N. Saleem Basha, Kewani Ghirmay and Melles Kahsase. In silico comparison of interleukin-2 of Homo sapiens with different species. Pharma Focus: The journal of Eritrean Pharmaceutical Association (ERIPA), Vol. 14, Dec 10 2011, pp32-37.
N Saleem Basha
View PDFchevron_right
Isolation and characterization of modified species of a mutated (Cys 125–Ala) recombinant human interleukin-2
Vivian Morera, Vivian Huerta
Journal of Chromatography A, 2002
View PDFchevron_right
Purification of interleukin-2 antibodies from healthy individuals
Laura Tiberio
Immunology Letters, 1993
View PDFchevron_right
WHO cytokine standardization: facilitating the development of cytokines in research, diagnosis and as therapeutic agents
Ana Padilla
Journal of Immunological Methods, 1998
View PDFchevron_right
A simple and sensitive bioassay for the detection of IL-2 activity
Gustav Gaudernack
Journal of Immunological Methods, 1988
View PDFchevron_right
Plasma and Lymph Pharmacokinetics of Recombinant Human Interleukin-2 and Polyethylene Glycol-Modified Interleukin-2 in Pigs
Ronald Sawchuk
Journal of Pharmacology and Experimental Therapeutics, 2000
View PDFchevron_right
Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease
James E Talmadge
Cancer Research, 1987
View PDFchevron_right
A modified in situ enzyme-linked immunosorbent assay for quantitating interleukin-2 activity employing monoclonal anti-IL-2 receptor antibody
Joseph Igietseme
Journal of Immunological Methods, 1988
View PDFchevron_right
Antibodies of Predetermined Specificity against Chemically Synthesized Peptides of Human Interleukin 2
Jose Luis Cardenas
Proceedings of The National Academy of Sciences, 1984
View PDFchevron_right
Purification and refolding of Escherichia coli -expressed recombinant human interleukin-2
samaneh esfandiar
Biotechnology and Applied Biochemistry, 2010
View PDFchevron_right
Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease. Cancer Res 47: 5725-5732
James E Talmadge
Cancer Research
View PDFchevron_right
Human Interleukin 2 (IL-2) Promotion of Immune Regulation and ClinicalOutcomes: A Review
Claudia Regina Bonini Domingos
Journal of Cytokine Biology, 2016
View PDFchevron_right
Production of Genetically Engineered Biotinylated Interleukin-2 and Its Application in a Rapid Nonradioactive Assay for T-Cell Activation
Mark Preissler
Clinical and Vaccine Immunology, 2003
View PDFchevron_right
Molecular cloning of human interleukin 2 cDNA and its expression in E. coli
Guus Simons
Nucleic Acids Research, 1983
View PDFchevron_right
Scale-up Purification of a Mutant of Recombinant Human Interleukin 2 by Reverse-phase High Performance Liquid Chromatography
Danny Rodriguez
View PDFchevron_right
Detection and quantitation of interleukin-2 from individual cells
Susan Viselli
Journal of Immunological Methods, 1989
View PDFchevron_right
The Evaluation of Subcutaneous Proleukin® (interleukin-2) in a Randomized International Trial
Sean Emery
Controlled Clinical Trials, 2002
View PDFchevron_right
The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responses
Martin Ashdown
Cancer Management and Research, 2012
View PDFchevron_right
Improved culture conditions for quantitative evaluation of interleukin 2 production by frozen human lymphocytes
Annick Harel-bellan
Journal of Immunological Methods, 1983
View PDFchevron_right
Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells
joel depper
Journal of Experimental Medicine, 1985
View PDFchevron_right
Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera
mark klempner
Clinical cancer research : an official journal of the American Association for Cancer Research, 1996
View PDFchevron_right
CD4 Cell Response to 3 Doses of Subcutaneous Interleukin 2: Meta-analysis of 3 Vanguard Studies
Marcelo H Losso
Clinical Infectious Diseases, 2004
View PDFchevron_right
Optimized conditions for high-level expression and purification of recombinant human interleukin-2 in E. coli
Kapil Maithal
Indian journal of biochemistry & biophysics, 2008
View PDFchevron_right
[4]. Validation of biological actiVity testing procedure of recombinant human interleukin-7
Nguyen Huy Hoang
View PDFchevron_right